5 Jun 13 Form 605 - Notice of Ceasing to be a Substantial Holder
31 May 13 Form 605 - Notice of Ceasing to be a Substantial Holder
29 May 13 Form 604 - Notice of Change of Interest of Substantial Holder
29 May 13 Form 603 - Notice of Initial Substantial Holder
29 May 13 Notice Under Section 708A(5)(e)
28 May 13 Change in Substantial Holding

Site Map

Home

Latest news
Email alerts
Fact sheets
Presentations

Our Company

Our vision
Company summary
Our board of directors
Our management team
Contacts

Our Technology

Our technology
Angiogenesis
Cell proliferation
Epigenetics
Publications
Presentations
Glossary

Our Pipeline

Angiogenesis

PG545

Heparanase program

Cell proliferation

PG11047 monotherapy (solid tumors)

PG11047 combination (solid tumors)

PG11000 series

Polyamine

Epigenetics

Epigenetics series

Study Information

Investor Centre

IR summary
Newsletter
Email alerts
Reports
Corporate presentations
ASX announcements
ASX shareholder centre
NASDAQ shareholder centre
Corporate governance
Top holders
FAQ
Contacts